Found: 10
Select item for more details and to access through your institution.
lncRNA PANTR1 Upregulates BCL2A1 Expression to Promote Tumorigenesis and Warburg Effect of Hepatocellular Carcinoma through Restraining miR-587.
- Published in:
- 2021
- By:
- Publication type:
- journal article
UFMylation System: An Emerging Player in Tumorigenesis.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143501
- By:
- Publication type:
- Article
UFM1 inhibits hypoxia-induced angiogenesis via promoting proteasome degradation of HIF-1α.
- Published in:
- Molecular & Cellular Biochemistry, 2024, v. 479, n. 7, p. 1833, doi. 10.1007/s11010-024-05013-0
- By:
- Publication type:
- Article
Hsa_circ_0000345 regulates the cellular development of ASMCs in response to oxygenized low‐density lipoprotein.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 20, p. 11849, doi. 10.1111/jcmm.15801
- By:
- Publication type:
- Article
Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 9, p. 1, doi. 10.1038/s41419-023-06095-2
- By:
- Publication type:
- Article
β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 4, p. 1, doi. 10.1038/s41419-019-1492-6
- By:
- Publication type:
- Article
PRCC reduces the sensitivity of cancer cells to DNA damage by inhibiting JNK and ATM/ATR pathways and results in a poor prognosis in hepatocellular carcinoma.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00699-x
- By:
- Publication type:
- Article
miR-185-5p Regulates Inflammation and Phagocytosis through CDC42/JNK Pathway in Macrophages.
- Published in:
- Genes, 2022, v. 13, n. 3, p. 468, doi. 10.3390/genes13030468
- By:
- Publication type:
- Article
Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 5591, doi. 10.2147/OTT.S149632
- By:
- Publication type:
- Article
Simultaneous Overexpression of miR-126 and miR-34a Induces a Superior Antitumor Efficacy in Pancreatic Adenocarcinoma [Retraction].
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 2125, doi. 10.2147/OTT.S252412
- By:
- Publication type:
- Article